Ebola Update

Infection rates in Liberia decline; aid organizations struggle to procure gear; Merck enters the vaccine race; more

Written byMolly Sharlach
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, CDC GLOBAL

Ebola is no longer spreading exponentially in Liberia, US Centers for Disease Control and Prevention (CDC) Director Thomas Frieden announced last week (November 20), The New York Times reported. Frieden credited international aid efforts for curbing the spread of the infection, but stressed that similar responses were necessary to stem the epidemic in Guinea and Sierra Leone, which together continue to experience 1,000 to 2,000 new cases each week.

Meanwhile, aid organizations operating in West Africa are scrambling to obtain adequate supplies of personal protective equipment (PPE) for health-care workers, as well as other items, including powdered bleach and medical rehydration supplies. The CDC and US hospitals have bought up large stockpiles of these products in preparation for more potential cases of Ebola in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies